NO160263C - Analogifremgangsmaate til fremstilling av antibiotisk acetylerytromycistearat. - Google Patents

Analogifremgangsmaate til fremstilling av antibiotisk acetylerytromycistearat.

Info

Publication number
NO160263C
NO160263C NO850007A NO850007A NO160263C NO 160263 C NO160263 C NO 160263C NO 850007 A NO850007 A NO 850007A NO 850007 A NO850007 A NO 850007A NO 160263 C NO160263 C NO 160263C
Authority
NO
Norway
Prior art keywords
acetylerythromycistearate
antibiotic
preparation
analogy procedure
analogy
Prior art date
Application number
NO850007A
Other languages
English (en)
Norwegian (no)
Other versions
NO160263B (no
NO850007L (no
Inventor
Martti Lauri Antero Marvola
Esko Veikko Marttila
Jaakko Antero Uotila
Aino Kyllikki Pippuri
Pekka Juhani Kairisalo
Erkki Juhani Honkanen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of NO850007L publication Critical patent/NO850007L/no
Publication of NO160263B publication Critical patent/NO160263B/no
Publication of NO160263C publication Critical patent/NO160263C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
NO850007A 1984-01-06 1985-01-02 Analogifremgangsmaate til fremstilling av antibiotisk acetylerytromycistearat. NO160263C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (3)

Publication Number Publication Date
NO850007L NO850007L (no) 1985-07-08
NO160263B NO160263B (no) 1988-12-19
NO160263C true NO160263C (no) 1989-03-29

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
NO850007A NO160263C (no) 1984-01-06 1985-01-02 Analogifremgangsmaate til fremstilling av antibiotisk acetylerytromycistearat.

Country Status (38)

Country Link
US (1) US4599326A (en:Method)
JP (1) JPS60158197A (en:Method)
KR (1) KR900006237B1 (en:Method)
AT (1) AT386414B (en:Method)
AU (1) AU565688B2 (en:Method)
BE (1) BE901411A (en:Method)
BG (1) BG43189A3 (en:Method)
CA (1) CA1224461A (en:Method)
CH (1) CH666275A5 (en:Method)
CS (1) CS247191B2 (en:Method)
CY (1) CY1462A (en:Method)
DE (1) DE3500179A1 (en:Method)
DK (1) DK149776C (en:Method)
ES (1) ES8605818A1 (en:Method)
FI (1) FI77249C (en:Method)
FR (1) FR2557878B1 (en:Method)
GB (1) GB2152502B (en:Method)
HK (1) HK11590A (en:Method)
HU (1) HU196221B (en:Method)
IE (1) IE57967B1 (en:Method)
IL (1) IL73885A (en:Method)
IS (1) IS2968A7 (en:Method)
IT (1) IT1184304B (en:Method)
KE (1) KE3841A (en:Method)
LU (1) LU85721A1 (en:Method)
MA (1) MA20316A1 (en:Method)
MX (1) MX156277A (en:Method)
NL (1) NL8403979A (en:Method)
NO (1) NO160263C (en:Method)
NZ (1) NZ210606A (en:Method)
PH (1) PH22471A (en:Method)
PL (1) PL144349B1 (en:Method)
PT (1) PT79777B (en:Method)
RO (1) RO91262B (en:Method)
SE (1) SE461854B (en:Method)
SU (1) SU1410866A3 (en:Method)
YU (1) YU44485B (en:Method)
ZA (1) ZA8410143B (en:Method)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US7399488B2 (en) * 2002-07-05 2008-07-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US20050158374A1 (en) * 2003-10-31 2005-07-21 Wong Patrick S. Compositions and dosage forms for enhanced absorption of metformin
CA2569958C (en) 2004-06-12 2016-03-22 Jane C. Hirsh Abuse-deterrent drug formulations
EP2457580A1 (en) 2004-08-25 2012-05-30 The UAB Research Foundation Absorption enhancers for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
CA2743725A1 (en) 2006-06-23 2007-12-27 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
AU2012255116B2 (en) 2011-05-18 2017-05-25 Mederis Diabetes, Llc Improved peptide pharmaceuticals
WO2014081864A1 (en) 2012-11-20 2014-05-30 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
KR102213907B1 (ko) 2012-11-20 2021-02-09 메더리스 다이어비티즈, 엘엘씨 인슐린 저항성에 대한 개선된 펩티드 약제
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
CN117180445A (zh) 2014-05-28 2023-12-08 梅德瑞斯糖尿病有限责任公司 针对胰岛素抵抗的改良肽药物
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
RU2019142102A (ru) 2017-05-19 2021-06-21 Лунелла Байотек, Инк. Антимитосцины: направленные ингибиторы митохондриального биогенеза для эрадикации злокачественных стволовых клеток
US11497759B2 (en) 2017-12-01 2022-11-15 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
ES2791775B2 (es) 2018-02-06 2023-01-20 Aegis Therapeutics Llc Formulaciones de epinefrina intranasal y metodos para el tratamiento de enfermedades
US11918597B2 (en) * 2018-12-17 2024-03-05 Lunella Biotech, Inc. Triple combination therapies for anti-aging
WO2020131696A1 (en) * 2018-12-17 2020-06-25 Lunella Biotech, Inc. Triple combination therapies for targeting mitochondria and killing cancer stem cells
EA202091615A1 (ru) 2018-12-21 2021-03-05 Аегис Терапьютикс, Ллс Интраназальные составы на основе эпинефрина и способы лечения заболевания

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
FI850023A0 (fi) 1985-01-03
AT386414B (de) 1988-08-25
SE8406671D0 (sv) 1984-12-28
NO160263B (no) 1988-12-19
JPS60158197A (ja) 1985-08-19
PL144349B1 (en) 1988-05-31
SE8406671L (sv) 1985-07-07
DK149776C (da) 1987-04-21
IL73885A (en) 1988-10-31
FI77249C (fi) 1989-02-10
AU3705984A (en) 1985-07-11
PH22471A (en) 1988-09-12
IE850022L (en) 1985-07-06
FI77249B (fi) 1988-10-31
IE57967B1 (en) 1993-06-02
GB2152502B (en) 1987-10-07
HK11590A (en) 1990-02-23
KR900006237B1 (ko) 1990-08-27
CH666275A5 (de) 1988-07-15
BE901411A (fr) 1985-04-16
DE3500179A1 (de) 1985-07-18
ES8605818A1 (es) 1986-04-01
BG43189A3 (en) 1988-04-15
MX156277A (es) 1988-08-04
NZ210606A (en) 1987-08-31
JPH029040B2 (en:Method) 1990-02-28
IT8519012A0 (it) 1985-01-04
RO91262B (ro) 1987-07-01
ZA8410143B (en) 1985-08-28
US4599326A (en) 1986-07-08
CA1224461A (en) 1987-07-21
NO850007L (no) 1985-07-08
YU44485B (en) 1990-08-31
CS247191B2 (en) 1986-12-18
ATA985A (de) 1988-01-15
SU1410866A3 (ru) 1988-07-15
HU196221B (en) 1988-10-28
DK5884D0 (da) 1984-01-06
FR2557878A1 (fr) 1985-07-12
GB2152502A (en) 1985-08-07
DK5884A (da) 1985-07-07
MA20316A1 (fr) 1985-10-01
RO91262A (ro) 1987-06-30
DE3500179C2 (en:Method) 1989-08-24
FR2557878B1 (fr) 1988-01-15
CY1462A (en) 1989-07-21
HUT37628A (en) 1986-01-23
ES539349A0 (es) 1986-04-01
PT79777B (en) 1986-10-21
YU2085A (en) 1987-12-31
NL8403979A (nl) 1985-08-01
SE461854B (sv) 1990-04-02
KR850005452A (ko) 1985-08-26
PT79777A (en) 1985-01-01
IS2968A7 (is) 1985-04-03
KE3841A (en) 1989-04-07
DK149776B (da) 1986-09-29
GB8432368D0 (en) 1985-02-06
AU565688B2 (en) 1987-09-24
PL251457A1 (en) 1985-11-05
LU85721A1 (fr) 1985-07-24
IL73885A0 (en) 1985-03-31
FI850023L (fi) 1985-07-07
IT1184304B (it) 1987-10-28

Similar Documents

Publication Publication Date Title
NO160263C (no) Analogifremgangsmaate til fremstilling av antibiotisk acetylerytromycistearat.
NO874764D0 (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
FI852516A0 (fi) Anordning foer dosering av tillvaext befraemjande aemnen.
NO822722L (no) Fremgangsmaate til fremstilling av benzazepin-2-oner.
NO165757C (no) Fremgangsmaate til fremstilling av polyvinylklorid.
NO855163L (no) Fremgangsmaate for fremstilling av acylerte diketon-forbindelser.
NO861486L (no) Fremgangsmaate til fremstilling av fluorerte benzyltriazolforbindelser.
NO855067L (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
NO853066L (no) Fremgansmaate til fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO851310L (no) Stereospesifikk fremgangsmaate til fremstilling av acetonoksyazetidinon.
NO164030C (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO163061C (no) Fremgangsmaate til fremstilling av ferromangan.
NO156653C (no) Fremgangsmaate for fremstilling av et antibiotikum.
NO161064C (no) Analogifremgangsmaate til fremstilling av fenyl-nonatetraensyrederivater.
NO165637C (no) Fremgangsmaate for fremstilling av etoksylert lignitt.
NO863616D0 (no) Fremgangsmaate for fremstilling av n-sulfamyl-3-(2-guanidino-thiazolo-4-yl-methylthio)-propionamid.
NO870828D0 (no) Fremgangsmaate for fremstilling av biskarbamater.
NO161353C (no) Fremgangsmaate for fremstilling av pastiller.
NO863769D0 (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid.
NO161911C (no) Fremgangsmaate for fremstilling av sulfonater.
NO864087L (no) Fremgangsmaate for fremstilling av aroylthiazoloner.
NO166709C (no) Fremgangsmaate for fremstilling av akrylamider.
NO851319L (no) Fremgangsmaate for fremstilling av eburnanderivater.
NO821874L (no) Fremgangsmaate for fremstilling av fenoletere.
NO903305L (no) Fremgangsmaate for fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.